Search results (396)
« Back to PublicationsCAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.
Journal article
Rampotas A. et al, (2026), Sci Transl Med, 18
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.
Journal article
Pemmaraju N. et al, (2026), Blood
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.
Journal article
Gill H. et al, (2026), Blood Adv
Somatic and germline genetic testing pathways in haematological malignancies: Best practice consensus guidelines from the 2025 national meeting organised by UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.
Journal article
Speight B. et al, (2026), Br J Haematol, 208, 1211 - 1222
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.
Conference paper
Gagnon LL. et al, (2026), Leukemia
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders.
Journal article
Shen Y. et al, (2026), Cell Stem Cell, 33, 421 - 437.e7
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline.
Journal article
Godfrey AL. et al, (2026), Br J Haematol, 208, 471 - 485
Redefining the topology of the human bone marrow using augmented spatial transcriptomic analysis
Preprint
Cooper RA. et al, (2025)
Genome editing for treatment of JAK2 V617F-driven myeloproliferative neoplasms
Preprint
Doll RM. et al, (2025)
3062 – PLATELETS SEQUESTER EXTRACELLULAR DNA, CAPTURING TUMOR-DERIVED AND FREE FETAL DNA
Presentation
Murphy L. et al, (2025), Experimental Hematology, 151
Causal relevance of clonal haematopoiesis with cardiac disease and adverse remodelling: a Mendelian randomisation study.
Journal article
Morley AP. et al, (2025), Open Heart, 12
Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA.
Journal article
Murphy L. et al, (2025), Science, 389
SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2.
Journal article
Cho H-J. et al, (2025), EMBO Mol Med, 17, 2115 - 2136
Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML.
Journal article
Wang Z. et al, (2025), Blood, 146, 341 - 355